Activist 13D/13G Filings - Karyopharm Therapeutics Inc. (KPTI)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-13
4:06 pm
Purchase
13GKARYOPHARM THERAPEUTICS INC
KPTI
Kauffman Michael3,921,434
5.77%
314,994increase
(+8.73%)
View
2020-02-13
1:43 pm
Purchase
13GKARYOPHARM THERAPEUTICS INC
KPTI
STATE STREET CORP
STT
3,228,366
5.14%
3,228,366increase
(New Position)
View
2020-02-12
4:19 pm
Sale
13GKARYOPHARM THERAPEUTICS INC
KPTI
ADAGE CAPITAL PARTNERS GP L.L.C.3,787,000
6.03%
-213,000decrease
(-5.33%)
View
2020-02-06
5:07 pm
Sale
13GKARYOPHARM THERAPEUTICS INC
KPTI
INTEGRATED CORE STRATEGIES (US) LLC13,496
0%
-3,359,070decrease
(-99.60%)
View
2020-02-05
12:16 pm
Purchase
13GKARYOPHARM THERAPEUTICS INC
KPTI
BlackRock Inc.
BLK
4,768,926
7.6%
511,014increase
(+12.00%)
View
2019-11-18
5:22 pm
Purchase
13GKARYOPHARM THERAPEUTICS INC
KPTI
ADAGE CAPITAL PARTNERS GP L.L.C.4,000,000
6.37%
4,000,000increase
(New Position)
View
2019-11-08
09:03 am
Sale
13GKARYOPHARM THERAPEUTICS INC
KPTI
WELLINGTON MANAGEMENT GROUP LLP1,571,052
2.5%
-6,645,729decrease
(-80.88%)
View
2019-07-23
5:00 pm
Purchase
13GKARYOPHARM THERAPEUTICS INC
KPTI
INTEGRATED CORE STRATEGIES (US) LLC3,372,566
5.5%
3,372,566increase
(New Position)
View
Goto Prev, 0, 1, 2